Cory Perla

CHICAGO — In this video, Karl G. Csaky, MD, PhD, discusses highlights from the AAO annual meeting.In a panel discussion on dry age-related macular degeneration, experts debated the importance of anatomic vs. functional benefits of dry AMD therapies, according to Csaky, chief executive and medical officer of the Retina Foundation of the Southwest in Dallas.

CHICAGO —In this video, Karl G. Csaky, MD, PhD, highlights discussions from the AAO meeting on the adequacy of tools used to assess the effectiveness of treatments for dry age-related macular degeneration.

CHICAGO — In this video, Clement K. Chan, MD, FACS, discusses highlights from the AAO meeting, including presentations on pegcetacoplan and avacincaptad pegol for the treatment of geographic atrophy.In addition, Chan, a retina specialist at Desert Retina Consultants, recaps a panel discussion during which experts shared their opinions on the use of these therapies for the treatment of GA.

SAN DIEGO —In this video, Jennifer A. Woyach, MD, discusses results from the AMPLIFY trial, presented at ASH Annual Meeting and Exhibition.The trial evaluated fixed-duration acalabrutinib (Calquence, AstraZeneca) plus venetoclax (Venclexta, AbbVie) with or without obinutuzumab (Gazyva, Genentech) versus chemoimmunotherapy as front-line treatment for chronic lymphocytic leukemia.

SAN DIEGO —In this video, Jennifer A. Woyach, MD, discusses two abstracts from ASH Annual Meeting and Exhibition that evaluated the use of immune therapies to treat chronic lymphocytic leukemia.

SALT LAKE CITY — In this video, Jay Chhablani, MD, discusses preliminary data from the ArMaDa study of OCU410 gene therapy for geographic atrophy presented at the ARVO meeting.

In this Healio video, David G. Standaert, MD, PhD, discusses the Stanley Fahn Lecture Award presentation given at the 2025 International Congress of Parkinson’s Disease and Movement Disorders.

In this video, Leo I. Gordon, MD, FACP, discusses the growing view that follicular lymphoma could be viewed as “curable.”

COPENHAGEN, Denmark — In this Healio video, Alissa J. Cooper, MD, a thoracic oncologist at Dana-Farber Cancer Institute, discusses the TOP trial of osimertinib plus chemotherapy in high-risk patients with non-small cell lung cancer.

COPENHAGEN, Denmark — In this Healio video, Alissa J. Cooper, MD, a thoracic oncologist at Dana-Farber Cancer Institute, discusses results from the OptiTROP-Lung03 study, which were presented at European Lung Cancer Congress.